A novel detection method based on MIRA-CRISPR/Cas13a-LFD targeting the repeated DNA sequence of Trichomonas vaginalis

Zhenke Yang1, Jinghui Wang1, Yiming Qi1

  • 1Xinxiang Key Laboratory of Pathogenic Biology, Department of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.

Parasites & Vectors
|January 8, 2024
PubMed
Abstract

Insights

A new MIRA-CRISPR/Cas13a-LFD test accurately detects Trichomonas vaginalis, the leading cause of non-viral STIs. This rapid and convenient method offers improved diagnosis for vaginitis compared to existing techniques.

Area of Science:

  • Medical Diagnostics
  • Molecular Biology
  • Infectious Diseases

Background:

  • Trichomonas vaginalis is the most common non-viral sexually transmitted infection globally.
  • It is associated with pelvic inflammatory disease, adverse pregnancy outcomes, and increased HIV risk.
  • Current detection methods are expensive and complex.

Purpose of the Study:

  • To develop a novel, rapid, and accurate diagnostic tool for T. vaginalis detection.
  • To evaluate the performance of the new assay compared to existing methods.

Main Methods:

  • Development of a multi-enzyme isothermal rapid amplification-clustered regularly interspaced short palindromic repeats (MIRA-CRISPR)/Cas13a-lateral flow device (LFD) assay.
  • The assay targets a specific DNA sequence of T. vaginalis and operates at 37°C for approximately 1 hour.
  • Testing was performed on clinical samples and compared with microscopy, PCR, and culture.

Main Results:

  • The MIRA-CRISPR/Cas13a-LFD assay demonstrated a detection limit of 1 × 10⁻⁴ ng/μl.
  • The assay showed 100% sensitivity and excellent diagnostic agreement (kappa=1) with the gold standard culture method, similar to nested PCR.
  • No cross-reactivity was observed with DNA from other common microorganisms.

Conclusions:

  • The MIRA-CRISPR/Cas13a-LFD assay is a convenient, rapid, stable, and accurate diagnostic tool for T. vaginalis.
  • This method shows potential for improving vaginitis diagnosis and management.
  • It represents a significant advancement over current diagnostic techniques.

Related Concept Videos

CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.